Publicaties 2015/2016

Hieronder staat een selectie van wetenschappelijke publicaties door Nederlandse onderzoekers die betrekking hebben op het bevolkingsonderzoek op borstkanker, gepubliceerd in 2015 of 2016.

Bluekens AM, Veldkamp WJ, Schuur KH, Karssemeijer N, Broeders MJ, den Heeten GJ. The potential use of ultra-low radiation dose images in digital mammography–a clinical proof-of-concept study in craniocaudal views. Br J Radiol. 2015;88(1047):20140626.

van Bommel R, Voogd AC, Louwman MW, Strobbe LJ, Venderink D, Duijm LE. Screening outcome in women repeatedly recalled for the same mammographic abnormality before, during and after the transition from screen-film to full-field digital screening mammography. Eur Radiol. 2017;27(2):553-561.

Bouwman RW, van Engen RE, Young KC, den Heeten GJ, Broeders MJ, Schopphoven S, Jeukens CR, Veldkamp WJ, Dance DR. Average glandular dose in digital mammography and digital breast tomosynthesis: comparison of phantom and patient data. Phys Med Biol. 2015;60(20):7893-907.

Bouwman RW, van Engen RE, Young KC, Veldkamp WJ, Dance DR. Dose assessment in contrast enhanced digital mammography using simple phantoms simulating standard model breasts. Phys Med Biol. 2015;60(1):N1-7.

Bouwman RW, Binst J, Dance DR, Young KC, Broeders MJ, den Heeten GJ, Veldkamp WJ, Bosmans H, van Engen RE. Simulating local dense areas using PMMA to assess automatic exposure control in digital mammography. Radiat Prot Dosimetry. 2016;169(1-4):143-50.

Bouwman RW, van Engen RE, Broeders MJM, den Heeten GJ, Dance DR, Young KC, Veldkamp WJH. Can the non-pre-whitening model observer, including aspects of the human visual system, predict human observer performance in mammography? Phys Med. 2016;32:1559-69.

Bouwman RW, Goffi M, van Engen RE, Broeders MJM, Dance DR, Young KC, Veldkamp WJH. Can the channelized Hotelling observer including aspects of the human visual system predict human observer performance in mammography? Phys Med. 2016 Dec.

Broeders MJ, Ten Voorde M, Veldkamp WJ, van Engen RE, van Landsveld-Verhoeven C, ‘t Jong-Gunneman MN, de Win J, Greve KD, Paap E, den Heeten GJ. Comparison of a flexible versus a rigid breast compression paddle: pain experience, projected breast area, radiation dose and technical image quality. Eur Radiol. 2015;25(3):821-9.

Broeders M, Paci E. The balance sheet of benefits and harms of breast cancer population-based screening in Europe: outcome research, practice and future challenges. Womens Health (Lond Engl). 2015;11(6):883-90.

Elshof LE, Tryfonidis K, Slaets L, van Leeuwen-Stok AE, Skinner VP, Dif N, Pijnappel RM, Bijker N, Rutgers EJ, Wesseling J. Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ: The LORD study. Eur J Cancer. 2015;51(12):1497-510.

Emaus MJ, Bakker MF, Peeters PH, Loo CE, Mann RM, de Jong MD, Bisschops RH, Veltman J, Duvivier KM, Lobbes MB, Pijnappel RM, Karssemeijer N, de Koning HJ, van den Bosch MA, Monninkhof EM, Mali WP, Veldhuis WB, van Gils CH. MR imaging as an additional screening modality for the detection of breast cancer in women aged 50-75 years with extremely dense breasts: The DENSE trial study design. Radiology. 2015;277(2):527-37.

Geertse T, Holland R, Timmers JMH, Paap E, Pijnappel R, Broeders MJM, den Heeten GJ . Value of audits in breast cancer screening quality assurance programmes. Eur Radiol. 2015;25(11):3338-47

de Gelder R, Heijnsdijk EA, Fracheboud J, Draisma G, de Koning HJ. The effects of population-based mammography screening starting between age 40 and 50 in the presence of adjuvant systemic therapy. Int J Cancer. 2015;137(1):165-72.

de Groot JE, Broeders MJ, Grimbergen CA, den Heeten GJ. Pain-preventing strategies in mammography: an observational study of simultaneously recorded pain and breast mechanics throughout the entire breast compression cycle. BMC Womens Health. 2015;15(1):185.

de Groot JE, Branderhorst W, Grimbergen CA, den Heeten GJ, Broeders MJ. Towards personalized compression in mammography: a comparison study between pressure- and force-standardization. Eur J Radiol. 2015;84(3):384-91.

Heid P, Noel A, van Engen RE. Contrôle qualité en tomosynthèse : état des lieux. Breast tomosynthesis: Current state of quality control. Imagerie de la Femme (2016) 26, 181-183.

Holland K, van Zelst J, den Heeten GJ, Imhof-Tas M, Mann RM, van Gils CH, Karssemeijer N. Consistency of breast density categories in serial screening mammograms: A comparison between automated and human assessment. Breast. 2016;29:49-54.

Hooiveld M, Paap E. Verwijzingen bij klachten van de borst. Huisarts & Wetenschap. 2016;59(10):454.

Hubbard RA, Ripping TM, Chubak J, Broeders MJ, Miglioretti DL. Statistical Methods for Estimating the Cumulative Risk of Screening Mammography Outcomes. Cancer Epidemiol Biomarkers Prev. 2016 Mar;25(3):513-20.

Klompenhouwer EG, Voogd AC, den Heeten GJ, Strobbe LJ, de Haan AF, Wauters CA, Broeders MJ, Duijm LE. Blinded double reading yields a higher programme sensitivity than non-blinded double reading at digital screening mammography: a prospected population based study in the south of The Netherlands. Eur J Cancer. 2015;51(3):391-9.

Klompenhouwer EG, Weber RJ, Voogd AC, den Heeten GJ, Strobbe LJ, Broeders MJ, Tjan-Heijnen VC, Duijm LE. Arbitration of discrepant BI-RADS 0 recalls by a third reader at screening mammography lowers recall rate but not the cancer detection rate and sensitivity at blinded and non-blinded double reading. Breast. 2015;24(5):601-7.

de Koning HJ, Heijnsdijk E. Swiss Medical Board Mammography screening predictions for Switzerland: Importance of time-periods. J Med Screen. 2015;22(4):201-6.

Lalji UC, Houben IP, Prevos R, Gommers S, van Goethem M, Vanwetswinkel S, Pijnappel R, Steeman R, Frotscher C, Mok W, Nelemans P, Smidt ML, Beets-Tan RG, Wildberger JE, Lobbes MB. Contrast-
enhanced spectral mammography in recalls from the Dutch breast cancer screening program: validation of results in a large multireader, multicase study. Eur Radiol. 2016;26(12):4371-4379.

van Landsveld-Verhoeven C, Timmers JMH, den Heeten GJ, Broeders MJM. Mammographic positioning quality of newly trained versus experienced radiographers in the Dutch breast cancer screening programme. Eur Radiol. 2015;25(11):3322-7.

van Landsveld-Verhoeven C, den Heeten GJ, Timmers JM, Broeders MJ. De juiste instelling in borstkankerscreening. Ned Tijdschr Geneeskd. 2015;159(0):A9488.

van Luijt PA, Heijnsdijk EA, Fracheboud J, Overbeek LI, Broeders MJ, Wesseling J, den Heeten GJ, de Koning HJ. The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis in breast cancer screening. Breast Cancer Res. 2016 May 10;18(1):47.

van Luijt PA, Heijnsdijk EA, de Koning HJ. Cost-effectiveness of the Norwegian breast cancer screening program. Int J Cancer. 2017;140(4):833-840.

van Luijt PA, Heijnsdijk EA, van Ravesteyn NT, Hofvind S, de Koning HJ. Breast cancer incidence trends in Norway and estimates of overdiagnosis. J Med Screen. 2016. pii: 0969141316668379. [Epub ahead of print]

van Luijt PA, Rozemeijer K, Naber SK, Heijnsdijk EA, van Rosmalen J, van Ballegooijen M, de Koning HJ. The role of pre-invasive disease in overdiagnosis: A microsimulation study comparing mass screening for breast cancer and cervical cancer. J Med Screen. 2016;23(4):210-216.

de Munck L, de Bock GH, Otter R, Reiding D, Broeders MJ, Willemse PH, Siesling S. Digital vs screen-film mammography in population-based breast cancer screening: performance indicators and tumour characteristics of screen-detected and interval cancers. Br J Cancer. 2016 Aug 23;115(5):517-24.

Paap E, Witjes M, van Landsveld-Verhoeven C, Pijnappel RM, Maas AH, Broeders MJ. Mammography in females with an implanted medical device: impact on image quality, pain and anxiety. Br J Radiol. 2016 Oct;89(1066):20160142. van Ravesteyn NT, van Lier L, Schechter CB, Ekwueme DU, Royalty J,

Miller JW, Near AM, Cronin KA, Heijnsdijk EA, Mandelblatt JS, de Koning HJ. Transition from film to digital mammography: impact for breast cancer screening through the national breast and cervical cancer early detection program. Am J Prev Med. 2015;48(5):535-42. van Ravesteyn NT, Stout NK,

Schechter CB, Heijnsdijk EA, Alagoz O, Trentham-Dietz A, Mandelblatt JS, de Koning HJ. Benefits and harms of mammography screening after age 74 years: model estimates of overdiagnosis. J Natl Cancer Inst. 2015;107(7).

Ripping TM, van der Waal D, Verbeek AL, Broeders MJ. The relative effect of mammographic screening on breast cancer mortality by socioeconomic status. Medicine (Baltimore). 2016;95(31):e4335.

Ripping TM, Verbeek AL, Ten Haaf K, van Ravesteyn NT, Broeders MJ. Extrapolation of pre-screening trends: Impact of assumptions on overdiagnosis estimates by mammographic screening. Cancer Epidemiol. 2016;42:147-53.

Ripping TM, Hubbard RA, Otten JD, den Heeten GJ, Verbeek AL, Broeders MJ. Towards personalized screening: Cumulative risk of breast cancer screening outcomes in women with and without a first-degree relative with a history of breast cancer. Int J Cancer. 2016;138(7):1619-25.

Ripping TM, Verbeek AL, Broeders MJ. Overdiagnosis in cancer screening: the need for a standardized denominator. J Med Screen. 2015 Oct 13. pii: 0969141315604864. [Epub ahead of print]

Ripping TM, Verbeek AL, Fracheboud J, de Koning HJ, van Ravesteyn NT, Broeders MJ. Overdiagnosis by mammographic screening for breast cancer studied in birth cohorts in The Netherlands. Int J Cancer. 2015;137(4):921-9.

Sankatsing VD, Heijnsdijk EA, van Luijt PA, van Ravesteyn NT, Fracheboud J, de Koning HJ. Cost-effectiveness of digital mammography screening before the age of 50 in The Netherlands. Int J Cancer. 2015;137(8):1990-9.

Sardanelli F, Aase HS, Álvarez M, Azavedo E, Baarslag HJ, Balleyguier C, Baltzer PA, Beslagic V, Bick U, Bogdanovic-Stojanovic D, Briediene R, Brkljacic B, Camps Herrero J, Colin C, Cornford E, Danes J, de Geer G, Esen G, Evans A, Fuchsjaeger MH, Gilbert FJ, Graf O, Hargaden G, Helbich TH, Heywang-Köbrunner SH, Ivanov V, Jónsson Á, Kuhl CK, Lisencu EC, Luczynska E, Mann RM, Marques JC, Martincich L, Mortier M, Müller-Schimpfle M, Ormandi K, Panizza P, Pediconi F, Pijnappel RM, Pinker K, Rissanen T, Rotaru N, Saguatti G, Sella T, Slobodníková J, Talk M, Taourel P, Trimboli RM, Vejborg I, Vourtsis A, Forrai G. Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey. Eur Radiol. 2016 Nov 2. [Epub ahead of print]

Timmers J, Voorde MT, Engen RE, Landsveld-Verhoeven Cv, Pijnappel R, Greve KD, Heeten GJ, Broeders MJ. Mammography with and without radiolucent positioning sheets: Comparison of projected breast area, pain experience, radiation dose and technical image quality. Eur J Radiol. 2015;84(10):1903-9.

van der Waal D, Broeders MJ, Verbeek AL, Duffy SW, Moss SM. Case-control Studies on the Effectiveness of Breast Cancer Screening: Insights from the UK Age Trial. Epidemiology. 2015;26(4):590-6.

van der Waal D, Emaus MJ, Bakker MF, den Heeten GJ, Karssemeijer N, Pijnappel RM, Veldhuis WB, Verbeek AL, van Gils CH, Broeders MJ. Geographic variation in volumetric breast density between screening regions in the Netherlands. Eur Radiol. 2015;25(11):3328-37.

van der Waal D, den Heeten GJ, Pijnappel RM, Schuur KH, Timmers JM, Verbeek AL, Broeders MJ. Comparing Visually Assessed BI-RADS Breast Density and Automated Volumetric Breast Density Software: A Cross-Sectional Study in a Breast Cancer Screening Setting. PLoS One. 2015;10(9):e0136667.

Van der Waal D, Verbeek AL, den Heeten GJ, Ripping TM, Tjan-Heijnen VC, Broeders MJ. Breast cancer diagnosis and death in the Netherlands: a changing burden. Eur J Public Health. 2015;25(2):320-4.

van der Waal D, Ripping TM, Verbeek AL, Broeders MJ. Breast cancer screening effect across breast density strata: A case-control study. Int J Cancer. 2017;140(1):41-49.

Wanders JO, Holland K, Veldhuis WB, Mann RM, Pijnappel RM, Peeters PH, van Gils CH, Karssemeijer N. Volumetric breast density affects performance of digital screening mammography. Breast Cancer Res Treat. 2016 Dec 23. doi: 10.1007/s10549-016-4090-7. [Epub ahead of print]

Wanders JO, Bakker MF, Veldhuis WB, Peeters PH, van Gils CH. The effect of weight change on changes in breast density measures over menopause in a breast cancer screening cohort. Breast Cancer Res. 2015;17:74.

Weber RJ, van Bommel RM, Louwman MW, Nederend J, Voogd AC, Jansen FH, Tjan-Heijnen VC, Duijm LE. Characteristics and prognosis of interval cancers after biennial screen-film or full-field digital screening mammography. Breast Cancer Res Treat. 2016;158(3):471-83.

Weber RJ, van Bommel RM, Setz-Pels W, Voogd AC, Klompenhouwer EG, Louwman MW, Strobbe LJ, Tjan-Heijnen VC, Duijm LE. Type and Extent of Surgery for Screen-Detected and Interval Cancers at Blinded Versus Nonblinded Double-Reading in a Population-Based Screening Mammography Program. Ann Surg Oncol. 2016 Nov;23(12):3822-3830.

Weber RJ, Klompenhouwer EG, Voogd AC, Strobbe LJ, Broeders MJ, Duijm LE. Comparison of the diagnostic workup of women referred at non-blinded or blinded double reading in a population-based screening mammography programme in the south of the Netherlands. Br J Cancer. 2015;113(7):1094-8.

Weber RJ, Nederend J, Voogd AC, Strobbe LJ, Duijm LE. Screening outcome and surgical treatment during and after the transition from screen-film to digital screening mammography in the south of the Netherlands. Int J Cancer. 2015;137(1):135-43

Zelle SG, Baltussen R, Otten JD, Heijnsdijk EA, van Schoor G, Broeders MJ. Predicting the stage shift as a result of breast cancer screening in low- and middle-income countries: a proof of concept. J Med Screen. 2015;22(1):8-19.